1-[[4-[2-(5-CHLORO-2-METHOXYBENZAMIDO)-ETHYL]-PHENYL]-SULFONYL]-3-(5-HYDROXYPENTYL)-UREA
Compound with spectra: 1 NMR
![1-[[4-[2-(5-CHLORO-2-METHOXYBENZAMIDO)-ETHYL]-PHENYL]-SULFONYL]-3-(5-HYDROXYPENTYL)-UREA](/api/compound/FbYR2AlXc28.png?ph=true&h=300&w=458 "1-[[4-[2-(5-CHLORO-2-METHOXYBENZAMIDO)-ETHYL]-PHENYL]-SULFONYL]-3-(5-HYDROXYPENTYL)-UREA")
| SpectraBase Compound ID | FbYR2AlXc28 |
|---|---|
| InChI | InChI=1S/C22H28ClN3O6S/c1-32-20-10-7-17(23)15-19(20)21(28)24-13-11-16-5-8-18(9-6-16)33(30,31)26-22(29)25-12-3-2-4-14-27/h5-10,15,27H,2-4,11-14H2,1H3,(H,24,28)(H2,25,26,29) |
| InChIKey | SHPRJUHLZCLFGR-UHFFFAOYSA-N |
| Mol Weight | 497.99 g/mol |
| Molecular Formula | C22H28ClN3O6S |
| Exact Mass | 497.138735 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
1-[[4-[2-(5-CHLORO-2-METHOXYBENZAMIDO)-ETHYL]-PHENYL]-SULFONYL]-3-(4-HYDROXYBUTYL)-UREA
1-[[4-[2-(5-CHLORO-2-METHOXYBENZAMIDO)-ETHYL]-PHENYL]-SULFONYL]-3-(3-HYDROXYPROPYL)-UREA
1-[[4-[2-(5-CHLORO-2-METHOXYBENZAMIDO)-ETHYL]-PHENYL]-SULFONYL]-3-(2-HYDROXYETHYL)-UREA
(+)-1-[[4-[2-(5-CHLORO-2-METHOXYBENZAMIDO)-ETHYL]-PHENYL]-SULFONYL]-3-(2-HYDROXY-1S-METHYLETHYL)-UREA
ETHYL-4-[2-(5-CHLORO-2-METHOXYBENZAMIDO)-ETHYL]-BENZENE-SULFONAMIDE-CARBAMATE
5-chloro-2-methoxy-N-[(1,3,5-trimethyl-1H-pyrazol-4-yl)methyl]benzamide
5-chloro-N-(2,6-diethylphenyl)-2-methoxybenzamide
N-(1)-{[4'-(2''-Thienyl)methylenecarbonyl]phenyl}-5-chloro-2-methoxybenzamide
5-chloro-N-[5-(ethylsulfanyl)-1,3,4-thiadiazol-2-yl]-2-methoxybenzamide
5-chloro-N-{6-[(5-chloro-2-methoxybenzoyl)amino]-2-pyridinyl}-2-methoxybenzamide
| Title | Journal or Book | Year |
|---|---|---|
| Hydroxyl-Substituted sulfonylureas as potent inhibitors of specific [3H]Glyburide binding to rat brain synaptosomes | Bioorganic & Medicinal Chemistry | 2003 |